Indiana University School of Medicine - Indianapolis — Indianapolis, Indiana

Indiana University School of Medicine - Indianapolis is a clinical research site located in Indianapolis, Indiana, United States 46202.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Indiana University School of Medicine - Indianapolis has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Alpha1-Antitrypsin Deficiency, Primary Biliary Cholangitis, Compensated Cirrhosis.

Sponsors: Takeda, Kowa Research Institute, Inc., Ionis Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Indiana University School of Medicine - Indianapolis?

Indiana University School of Medicine - Indianapolis has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Indiana University School of Medicine - Indianapolis conducted?

Indiana University School of Medicine - Indianapolis has 5 clinical trials on record, with 2 currently active. Their work covers Alpha1-Antitrypsin Deficiency, Primary Biliary Cholangitis, Compensated Cirrhosis.

Is Indiana University School of Medicine - Indianapolis accredited by Crixeo Health?

Yes — Indiana University School of Medicine - Indianapolis holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Indiana University School of Medicine - Indianapolis?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.